GlassScriptPhysician profile
Alan B Moy
NPI 1699799957
$1,750.40
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $285 · 2020: $409 · 2021: $353 · 2022: $607 · 2023: $96.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $61.15 · Education: $35.52.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $61.15 |
| Education | $35.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $618.40 | 2019-2023 | Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $420.63 | 2019-2023 | Ofev |
| Sunovion Pharmaceuticals INC. | $252.66 | 2019-2021 | |
| Glaxosmithkline, LLC. | $82.86 | 2020-2022 | |
| Mylan Specialty L.P. | $71.95 | 2020-2022 | |
| Grifols USA, LLC | $48.35 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $44.22 | 2021 | |
| Philips North America LLC | $41.79 | 2019-2022 | |
| Baxter Healthcare | $38.04 | 2022 | |
| Electromed, INC. | $31.96 | 2022-2023 | Smartvest |
| Resmed Corp | $31.59 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $26.86 | 2022 | |
| Shire North American Group INC | $15.52 | 2019 | |
| Inogen, INC. | $13.84 | 2022 | |
| Advanced Respiratory, INC | $11.73 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Moy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.